These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7822311)

  • 1. A new TEM beta-lactamase double mutant with broadened specificity reveals substrate-dependent functional interactions.
    Viadiu H; Osuna J; Fink AL; Soberón X
    J Biol Chem; 1995 Jan; 270(2):781-7. PubMed ID: 7822311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.
    Cantu C; Huang W; Palzkill T
    J Biol Chem; 1996 Sep; 271(37):22538-45. PubMed ID: 8798421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.
    De Wals PY; Doucet N; Pelletier JN
    Protein Sci; 2009 Jan; 18(1):147-60. PubMed ID: 19177359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of TEM-1 beta-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime.
    Venkatachalam KV; Huang W; LaRocco M; Palzkill T
    J Biol Chem; 1994 Sep; 269(38):23444-50. PubMed ID: 8089110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectral kinetic study of acylation and deacylation during the hydrolysis of penicillins and cefotaxime by beta-lactamase TEM-1 and the G238S mutant.
    Saves I; Burlet-Schiltz O; Maveyraud L; Samama JP; Promé JC; Masson JM
    Biochemistry; 1995 Sep; 34(37):11660-7. PubMed ID: 7547898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
    Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of threonine-to-methionine substitution at position 265 on structure and function of TEM-1 beta-lactamase.
    Huang W; Le QQ; LaRocco M; Palzkill T
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2266-9. PubMed ID: 7840555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam.
    Sowek JA; Singer SB; Ohringer S; Malley MF; Dougherty TJ; Gougoutas JZ; Bush K
    Biochemistry; 1991 Apr; 30(13):3179-88. PubMed ID: 1901218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
    Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
    FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial sensor for new-generation cephalosporins based in a protein-engineered beta-lactamase.
    García JL; Nuñez CJ; González EG; Osuna J; Soberón X; Galindo E
    Appl Biochem Biotechnol; 1998; 73(2-3):243-56. PubMed ID: 9779580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
    Raquet X; Lamotte-Brasseur J; Fonzé E; Goussard S; Courvalin P; Frère JM
    J Mol Biol; 1994 Dec; 244(5):625-39. PubMed ID: 7990143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of residue 238 of TEM-1 beta-lactamase in the hydrolysis of extended-spectrum antibiotics.
    Cantu C; Palzkill T
    J Biol Chem; 1998 Oct; 273(41):26603-9. PubMed ID: 9756899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins.
    Raquet X; Vanhove M; Lamotte-Brasseur J; Goussard S; Courvalin P; Frère JM
    Proteins; 1995 Sep; 23(1):63-72. PubMed ID: 8539251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple substitutions at position 104 of beta-lactamase TEM-1: assessing the role of this residue in substrate specificity.
    Petit A; Maveyraud L; Lenfant F; Samama JP; Labia R; Masson JM
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):33-40. PubMed ID: 7826350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli.
    Vakulenko SB; Taibi-Tronche P; Tóth M; Massova I; Lerner SA; Mobashery S
    J Biol Chem; 1999 Aug; 274(33):23052-60. PubMed ID: 10438473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered β-Lactamase Selection Approach for Site-Directed Mutagenesis.
    Forloni M; Liu AY; Wajapeyee N
    Cold Spring Harb Protoc; 2018 Aug; 2018(8):. PubMed ID: 30068589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases.
    Caniça MM; Barthélémy M; Gilly L; Labia R; Krishnamoorthy R; Paul G
    Antimicrob Agents Chemother; 1997 Feb; 41(2):374-8. PubMed ID: 9021194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of Asp for Asn at position 132 in the active site of TEM beta-lactamase. Activity toward different substrates and effects of neighboring residues.
    Osuna J; Viadiu H; Fink AL; Soberón X
    J Biol Chem; 1995 Jan; 270(2):775-80. PubMed ID: 7822310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital.
    Perilli M; Celenza G; Fiore M; Segatore B; Pellegrini C; Luzzaro F; Rossolini GM; Amicosante G
    J Antimicrob Chemother; 2007 Oct; 60(4):877-80. PubMed ID: 17673478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.